Sunshine Biopharma Inc (SBFM : NASDAQ)
Common Stock
$0.70
USD
+0.30 (75.92%)
Last updated: 2026-10-07
Follow SBFM
SBFM
Sunshine Biopharma Inc
WealthAwesomePerformance
1 Day
+75.92%
1 Week
-9.44%
1 Month
-38.60%
YTD
-66.98%
Key Statistics
Market Cap
$1.72M
52W High
$24.30
52W Low
$0.36
P/E Ratio
-
50 Day MA
$1.06
200 Day MA
$6.60
Beta
1.35
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/7/2026 | $0.41 | $1.54 | $0.40 | $0.70 | $0.70 | 171,328,018 |
| 10/6/2026 | $0.43 | $0.43 | $0.36 | $0.40 | $0.40 | 4,505,335 |
| 10/5/2026 | $0.48 | $0.50 | $0.41 | $0.42 | $0.42 | 2,051,761 |
| 10/2/2026 | $0.71 | $0.75 | $0.67 | $0.67 | $0.67 | 135,300 |
| 10/1/2026 | $0.78 | $0.78 | $0.67 | $0.69 | $0.69 | 129,298 |
| 9/30/2026 | $0.81 | $0.83 | $0.77 | $0.77 | $0.77 | 45,253 |
| 9/29/2026 | $0.81 | $0.81 | $0.78 | $0.79 | $0.79 | 37,509 |
| 9/28/2026 | $0.83 | $0.85 | $0.82 | $0.82 | $0.82 | 37,345 |
| 9/25/2026 | $0.84 | $0.86 | $0.80 | $0.84 | $0.84 | 131,500 |
| 9/24/2026 | $0.87 | $0.88 | $0.78 | $0.80 | $0.80 | 190,500 |
Analyst Price Targets
Based on 1 analyst covering SBFM · as of Sep 17, 2026
Wall Street analysts forecast SBFM stock price to rise 7900.0% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$56.00
+7900.0% Upside
Current Price
US$0.70
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SBFM's historical volatility
30-Day Vol
234.0%
Annualized
90-Day Vol
155.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$0.59
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.66 | US$0.29 – US$1.48 |
| 60 trading days | US$0.62 | US$0.20 – US$1.95 |
| 90 trading days | US$0.59 | US$0.14 – US$2.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Sunshine Biopharma Inc
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Financials
- Revenue (TTM)
- $35.35M
- EBITDA
- $-4.85M
- Profit Margin
- -16.50%
- ROE (TTM)
- -21.92%
- EPS (Diluted)
- -9.45
- Book Value
- 11.52
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SBFM.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GLE | Global Engine Group Holding Limited Ordinary Shares | $4.00 | +877.02% |
| SXTC | China SXT Pharmaceuticals Inc | $2.83 | +126.40% |
| PFAI | Pinnacle Food Group Limited Class A Common Shares | $5.07 | +116.67% |
| CHARR | Charlton Aria Acquisition Corporation Rights | $0.18 | +80.00% |
| BIYA | Baiya International Group Inc. Ordinary Shares | $2.30 | +68.50% |
| FEED | ENvue Medical Inc. | $0.43 | +50.84% |
| QETAR | Quetta Acquisition Corporation Right | $0.72 | +47.94% |
| NCPL | Netcapital Inc | $1.59 | +45.87% |